I'm a Senior Scientist specializing in ADCs, vaccines, protein chemistry, structural biology, small molecule, and biochemistry. I manage analytical development projects, guiding them from early phase to commercialization, including successful IND and ANDA filings. My blend of technical expertise and leadership fits roles in innovative and collaborative biotherapeutics.CAREER HIGHLIGHTS• Led the development and validation of complex LC-MS-MS analytical methods for ADC payloads, overcoming technical challenges within strict timelines, crucial for IND filings. (Abzena)• Authored over 200 analytical documents, including SOPs, methods, and validation reports, demonstrating exceptional documentation and technical writing skills. (All)• Authored the analytical section of the Bioequivalence Studies with Pharmacokinetic Endpoints report, submitted under an Abbreviated New Drug Application (ANDA) to the FDA for approval, completing it ahead of the company's deadline and saving over $450,000. (SPH Phililab Inc.)• Led training for QC Chemists in areas like dissolution, HPLC, and GC, which notably reduced incidents, deviations, and rework, achieving over a 20% boost in productivity and significant cost savings.